You are here

Press release

38 Catalan companies and organizations to participate in BIO Boston

04.06.2018

Barcelona, 4 June 2018.- A total of 38 Catalan companies and organizations will be participating in BIO Convention 2018, the top global biotechnology fair, held this year in Boston (United States) from 4 to 6 June. The Catalan delegation, coordinated by Biocat, makes up half of all of the Spanish companies participating in the fair, with 11 pharmaceutical corporations, 16 biotechnology firms, 2 service companies and 9 organizations and research entitites.

The Catalan delegation features pharmaceutical companies Almirall, ASCIL Biopharm Esteve, Ferrer Internacional, Gebro Pharma, GP Pharm, Grifols, Ipsen, Laboratorios Salvat, i LACER; biotechnology firms Acellera, Ahead Therapeutics, Archivel Farma, BCN Peptides, Bionure, Biokit, Cytes Biotechnologies, IDP Discovery Pharma, Iproteos, Nostrum Biodiscovery, Oryzon Genomics, ProteoDesign, Readycell, Spherium Biomed, Thrombotargets i ZeClinics; and consultancy and services companies BioSeed Capital  i TrifermedCBDO.

There will also be 8 institutions and research entities participating: Biocat, Center for Genomic Regulation (CRG), Bellvitge Biomedical Research Institute, Institute for Health Science Research Germans Trias i Pujol, Institute for Research in Biomedicine Barcelona (IRB), Institut Químic de Sarrià (IQS), Vall d’Hebron Research Institute (VHIR), Parc Científic de Barcelona (PCB) and Universitat Autònoma de Barcelona (UAB).

 

About the BioRegion of Catalonia

The BioRegion of Catalonia is made up of 871 companies which post yearly turnover of €15.956 billions and employ 42,133 workers, and 95 research bodies. One new life sciences company is created each week in the BioRegion of Catalonia,

The BioRegion of Catalonia measures up to European countries such as Austria, Belgium, Denmark, Ireland, Finland or Sweden. Catalonia is among the top four European countries in terms of number of companies in the healthcare sector per inhabitant. Specifically, it has more pharmaceutical companies per capita than any country in Europe except Belgium. Catalonia is also ranked fourth among European countries in terms of biotechnology companies per inhabitant (behind Sweden, Switzerland and Israel) and fourth in medical technology companies (behind Israel, Sweden and Switzerland).

 

About Biocat

Biocat, the organization that champions the healthcare and life sciences ecosystem in Catalonia, has experience in accelerating healthcare projects and developing talent since 2008. In ten years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions.

Call date: 
04.06.2018